Latest News
10% Sell-off Sparked as Adobe Q4 Earnings Misses Estimates
Adobe (NASDAQ: ADBE) stock fell sharply in mid-market trading on Thursday, after posting Q3 earnings that didn’t match up to the Wall Street consensus. Despite posting record Q4 earnings, the stock tanked around 10% as
Plug Power Investors Hesitant on Partnerships, What’s Really Going On?
Plug Power (NASDAQ: PLUG) stock opened on Thursday with a gain of just under 3%. The main flagbearer in the advocation of a hydrogen-based economy looks to be
Fed Decision Gives Breathing Room for Nio Stock, Should You Buy Now?
Investors latch on to easing inflation, market bulls welcomed back Uptick in Nio and other EV stocks as buyer confidence spur momentum Market de-listing and sector saturation continues to weigh on stock
SoFi Technologies Bounces Near Annual Lows, Gains on the Horizon?
SoFi stock sits near annual lows as investor sell-off and inflation fears weigh on price Covid, positive Q3, and the increase in mobile finance support SoFi growth Stock reacting around the $14.50 support zone, pot
Callliditas Therapeutics (CALT) Stock Price Surged 45.1% on FDA’s Approval of TARPEYO
Key Points: Calliditas stock price surged 45.1% on FDA’s approval of TARPEYO. The company is yet to complete the phase 3 trial of TARPEYO, but the phase 3 clinical study met its primary
Kaixin Auto (KXIN) Stock Price Soared Up to 51.6% on a $500M Order for EV Trucks
Key Points: Kaixin Auto stock rallied 51.6% premarket after receiving an order worth $500 million. Since January, the company’s shares have fallen 66.8% and could stage a comeback.
Roku’s Falling On Business Worries, Not The Patent Dispute
Roku (NASDAQ: ROKU) was down 8% yesterday, up 2% premarket today There was a release on the UEC patent dispute but that looks like a very minor influence
Eqtec Shares Edged 4% Higher on Strategic Partnerships Update. What’s Next?
Key Points: Eqtec shares edged higher after issuing an update on its strategic partnerships. Investors barely reacted to the news, which had minimal impact on the company’s finances.
S&P 500 Up 90 Points On FOMC And Fed Taper News
The S&P 500 reacts to monetary and macroeconomic news so the information from the Fed’s Open Market Committee has moved it 90 points
Kanabo Shares Barely Moved Despite Materia Starting EU Medical Cannabis Distribution
Key Points: Kanabo shares barely moved on news that Meteria Ltd, its partner, had started distributing cannabis products in the EU. Investors were unimpressed with the news since Kanabo
Kodal Minerals Up 30% Since Mali Prospects Update And Interims
Kodal Minerals (LON: KOD) stock is up some 30% since we looked a
Here’s Why Cineworld Is the Most Shorted Stock in London
Key Points: About 8.80% of Cineworld’s shares are sold short, making it the most shorted London-listed company. Since January, the cinema operator’s shares have fallen 52.7% and are like
Eurasia Mining Up 10% On Nickel Mineral Resource Report
Eurasia Mining (LON: EUA) shares have risen 10% on the back of resource news The NKT mine on the Kola Peninsula reports in substantial Tier-1 resources of
Abingdon Health Follows Genedrive With CE Application
Abingdon Health (LON: ABDX) has had certain problems with the DHSC reluctant to pay the company’s invoices. Genedrive (LON: GDR) has done very well in the
The Boohoo Share Price Plunged 20.5% on the Q3 Update. Can the Retailer Recover?
Key Points: Boohoo shares plunged 20.5% on Q3 trading update, lower full-year guidance. The retailer experienced high returns and slower deliveries due to COVID-19.
Lloyds, NatWest, Could Benefit More From BoE Interest Rate Rise Than Barclays And HSBC
The Bank of England is expected to raise interest rates in the near future Lloyds and NatWest to benefit Barclays and HSBC will be less affected The Bank of England is g
Investors are Looking to Banking Stocks For 2022, Here’s Why…
It’s been a whirlwind of a year, or two. We’ve seen economic downpour’s reminiscent of history’s bleakest periods, borne witness to the rise and ultimate
Gemini Therapeutics (GMTX) Stock Soared 45.3% on Positive Analyst Coverage. Is It a Buy?
Key points: Gemini Therapeutics stock price soared 45.3% during premarket trading. Analysts at H.C. Wainwright started covering Gemini with a buy rating. Other
Should You Buy Goldman Sachs Stock After Amping Up Solar Portfolio?
Goldman Sachs to partner with Dynamic Energy Solutions for 70MWS Maine-based solar project Set over 11 sites, the partnership will benefit large companies and landowners throughout the state The market failed to re
Palantir Stock Price Has Fallen 31.17% in Three Months. Is the Downtrend Over?
Key Points: Palantir stock price has fallen 31.2% in the past three months. Temporary factors have driven the downtrend. The company’s stock chart indicates that the do